• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

位置,位置,位置:从铁载体转运系统中建立新型抗菌药物的设计原则。

Location, Location, Location: Establishing Design Principles for New Antibacterials from Ferric Siderophore Transport Systems.

机构信息

Department of Chemistry, University of Connecticut, 55 N. Eagleville Road, U3060, Storrs, CT 06269, USA.

出版信息

Molecules. 2024 Aug 16;29(16):3889. doi: 10.3390/molecules29163889.

DOI:10.3390/molecules29163889
PMID:39202968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11357680/
Abstract

This review strives to assemble a set of molecular design principles that enables the delivery of antibiotic warheads to Gram-negative bacterial targets (ESKAPE pathogens) using iron-chelating siderophores, known as the Trojan Horse strategy for antibiotic development. Principles are derived along two main lines. First, archetypical siderophores and their conjugates are used as case studies for native iron transport. They enable the consideration of the correspondence of iron transport and antibacterial target location. The second line of study charts the rationale behind the clinical antibiotic cefiderocol. It illustrates the potential versatility for the design of new Trojan Horse-based antibiotics. Themes such as matching the warhead to a location where the siderophore delivers its cargo (i.e., periplasm vs. cytoplasm), whether or not a cleavable linker is required, and the relevance of cheaters to the effectiveness and selectivity of new conjugates will be explored. The effort to articulate rules has identified gaps in the current understanding of iron transport pathways and suggests directions for new investigations.

摘要

本综述旨在汇集一套分子设计原则,使抗生素弹头能够使用铁螯合的铁载体递送至革兰氏阴性细菌靶标(ESKAPE 病原体),这被称为抗生素开发的“特洛伊木马”策略。这些原则主要有两条主线得出。首先,典型的铁载体及其缀合物被用作天然铁转运的案例研究,使我们能够考虑铁转运与抗菌靶标位置之间的对应关系。其次,研究了临床抗生素头孢他啶的基本原理。它说明了基于“特洛伊木马”的新型抗生素设计的潜在多功能性。将弹头与铁载体输送货物的位置相匹配(即周质与细胞质)、是否需要可裂解的连接子,以及“骗子”对新缀合物的有效性和选择性的相关性等主题,都将得到探讨。阐明规则的努力确定了当前对铁转运途径理解的差距,并为新的研究方向提供了建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/1752672a93ad/molecules-29-03889-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/323d3ae00e99/molecules-29-03889-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/ab428514b882/molecules-29-03889-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/45d2281c0bb5/molecules-29-03889-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/4c46b4c43fe7/molecules-29-03889-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/f49aa4554f0d/molecules-29-03889-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/f3330ca1100d/molecules-29-03889-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/31b5c890a18f/molecules-29-03889-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/b4a612a5f264/molecules-29-03889-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/683a66d06e17/molecules-29-03889-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/41c795981245/molecules-29-03889-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/5ced06e71736/molecules-29-03889-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/5b6451956697/molecules-29-03889-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/f80128a51ee4/molecules-29-03889-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/60ab22076aef/molecules-29-03889-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/2cfc0e08ff05/molecules-29-03889-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/2fc290129319/molecules-29-03889-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/2a1bbff6a376/molecules-29-03889-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/1d75d2cb3786/molecules-29-03889-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/1752672a93ad/molecules-29-03889-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/323d3ae00e99/molecules-29-03889-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/ab428514b882/molecules-29-03889-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/45d2281c0bb5/molecules-29-03889-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/4c46b4c43fe7/molecules-29-03889-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/f49aa4554f0d/molecules-29-03889-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/f3330ca1100d/molecules-29-03889-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/31b5c890a18f/molecules-29-03889-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/b4a612a5f264/molecules-29-03889-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/683a66d06e17/molecules-29-03889-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/41c795981245/molecules-29-03889-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/5ced06e71736/molecules-29-03889-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/5b6451956697/molecules-29-03889-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/f80128a51ee4/molecules-29-03889-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/60ab22076aef/molecules-29-03889-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/2cfc0e08ff05/molecules-29-03889-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/2fc290129319/molecules-29-03889-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/2a1bbff6a376/molecules-29-03889-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/1d75d2cb3786/molecules-29-03889-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d954/11357680/1752672a93ad/molecules-29-03889-g019.jpg

相似文献

1
Location, Location, Location: Establishing Design Principles for New Antibacterials from Ferric Siderophore Transport Systems.位置,位置,位置:从铁载体转运系统中建立新型抗菌药物的设计原则。
Molecules. 2024 Aug 16;29(16):3889. doi: 10.3390/molecules29163889.
2
[Discovery of a New Siderophore Cephalosporin, Cefiderocol].[新型铁载体头孢菌素头孢地尔的发现]
Yakugaku Zasshi. 2024;144(6):627-631. doi: 10.1248/yakushi.23-00197-1.
3
Exploring the Antibacterial Activity and Cellular Fates of Enterobactin-Drug Conjugates That Target Gram-Negative Bacterial Pathogens.探索靶向革兰氏阴性细菌病原体的肠菌素-药物偶联物的抗菌活性和细胞命运。
Acc Chem Res. 2024 Apr 2;57(7):1046-1056. doi: 10.1021/acs.accounts.3c00814. Epub 2024 Mar 14.
4
Siderophore-Antibiotic Conjugate Design: New Drugs for Bad Bugs?铁载体-抗生素缀合物设计:针对坏菌的新药?
Molecules. 2019 Sep 11;24(18):3314. doi: 10.3390/molecules24183314.
5
Siderophore-drug complexes: potential medicinal applications of the 'Trojan horse' strategy.铁载体-药物复合物:“特洛伊木马”策略的潜在医学应用。
Trends Pharmacol Sci. 2014 Sep;35(9):442-9. doi: 10.1016/j.tips.2014.06.007. Epub 2014 Aug 6.
6
The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics.铁和铁载体在感染中的作用,以及铁载体抗生素的发展。
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S529-S537. doi: 10.1093/cid/ciz825.
7
Exploring the Localization of Siderophore-Mediated Cargo Delivery in Gram-Negative Bacteria Using 3-Hydroxypyridin-4(1)-one-Fluorescein Probes.用 3-羟基吡啶-4(1)-酮-荧光素探针探索革兰氏阴性菌中铁载体介导的货物传递的定位。
ACS Infect Dis. 2024 Jun 14;10(6):2303-2317. doi: 10.1021/acsinfecdis.4c00287. Epub 2024 May 9.
8
Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa.依赖铁载体的铁摄取系统作为对抗铜绿假单胞菌的抗生素特洛伊木马策略的门户。
Metallomics. 2014 Mar;6(3):408-20. doi: 10.1039/c3mt00359k. Epub 2014 Jan 31.
9
Experimental Methods for Evaluating the Bacterial Uptake of Trojan Horse Antibacterials.评估特洛伊木马抗菌剂细菌摄取量的实验方法
ChemMedChem. 2021 Apr 8;16(7):1063-1076. doi: 10.1002/cmdc.202000806. Epub 2020 Dec 10.
10
Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin.头孢地尔罗:一种新型铁载体头孢菌素的发现、化学结构和体内特征。
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S538-S543. doi: 10.1093/cid/ciz826.

本文引用的文献

1
Siderophore-mediated iron acquisition by .铁载体介导的 . 获取铁
J Bacteriol. 2024 May 23;206(5):e0002424. doi: 10.1128/jb.00024-24. Epub 2024 Apr 9.
2
PQS and pyochelin in share inner membrane transporters to mediate iron uptake.PQS 和 pyochelin 共用内膜转运体来介导铁摄取。
Microbiol Spectr. 2024 Feb 6;12(2):e0325623. doi: 10.1128/spectrum.03256-23. Epub 2024 Jan 3.
3
An Overview of Cefiderocol's Therapeutic Potential and Underlying Resistance Mechanisms.头孢地尔的治疗潜力及潜在耐药机制概述
Life (Basel). 2023 Jun 21;13(7):1427. doi: 10.3390/life13071427.
4
Revisiting ESKAPE Pathogens: virulence, resistance, and combating strategies focusing on quorum sensing.重新审视 ESKAPE 病原体:关注群体感应的毒力、耐药性和防治策略。
Front Cell Infect Microbiol. 2023 Jun 29;13:1159798. doi: 10.3389/fcimb.2023.1159798. eCollection 2023.
5
Pseudomonas aeruginosa FpvB Is a High-Affinity Transporter for Xenosiderophores Ferrichrome and Ferrioxamine B.铜绿假单胞菌 FpvB 是一种高亲和力的外源性铁载体运铁蛋白,可转运铁载体 Ferrichrome 和 Ferrioxamine B。
mBio. 2023 Feb 28;14(1):e0314922. doi: 10.1128/mbio.03149-22. Epub 2022 Dec 12.
6
Synthesis and Characterization of Preacinetobactin and 5-Phenyl Preacinetobactin.前阿替丁素和 5-苯前阿替丁素的合成与表征。
Molecules. 2022 Jun 9;27(12):3688. doi: 10.3390/molecules27123688.
7
Cryo-EM reveals unique structural features of the FhuCDB Escherichia coli ferrichrome importer.冷冻电镜揭示了大肠杆菌 ferrichrome 输入蛋白 FhuCDB 的独特结构特征。
Commun Biol. 2021 Dec 9;4(1):1383. doi: 10.1038/s42003-021-02916-2.
8
A role for PchHI as the ABC transporter in iron acquisition by the siderophore pyochelin in Pseudomonas aeruginosa.PchHI作为铜绿假单胞菌中铁载体绿脓菌素获取铁过程中的ABC转运蛋白的作用。
Environ Microbiol. 2022 Feb;24(2):866-877. doi: 10.1111/1462-2920.15811. Epub 2021 Oct 18.
9
Drugs That Changed Society: History and Current Status of the Early Antibiotics: Salvarsan, Sulfonamides, and β-Lactams.改变社会的药物:早期抗生素的历史和现状:砷凡纳明、磺胺类药物和β-内酰胺类药物。
Molecules. 2021 Oct 7;26(19):6057. doi: 10.3390/molecules26196057.
10
Structural and Biochemical Characterization of the Flavin-Dependent Siderophore-Interacting Protein from .来自……的黄素依赖性铁载体相互作用蛋白的结构与生化特性
ACS Omega. 2021 Jul 6;6(28):18537-18547. doi: 10.1021/acsomega.1c03047. eCollection 2021 Jul 20.